31 related articles for article (PubMed ID: 16785731)
1. Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline.
Dilger K; Zheng Z; Klotz U
Br J Clin Pharmacol; 1999 Sep; 48(3):438-44. PubMed ID: 10510158
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lysosomal enzyme activities by proton pump inhibitors.
Liu W; Baker SS; Trinidad J; Burlingame AL; Baker RD; Forte JG; Virtuoso LP; Egilmez NK; Zhu L
J Gastroenterol; 2013 Dec; 48(12):1343-52. PubMed ID: 23478938
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Syrian inbred hamster acetylator genotype to the mutagenic activation of 2-aminofluorene.
Yerokun T; Hein DW; Ferguson RJ; Ogolla F; Heflich RH; Minor TY; Trinidad A; Kirlin WG; Andrews AF
Mutagenesis; 1990 May; 5(3):233-9. PubMed ID: 2385177
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis.
Song HJ; Seo HJ; Jiang X; Jeon N; Lee YJ; Ha IH
Eur J Clin Pharmacol; 2024 Mar; 80(3):367-382. PubMed ID: 38147074
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.
Song HJ; Jiang X; Henry L; Nguyen MH; Park H
Eur J Clin Pharmacol; 2020 Jun; 76(6):851-866. PubMed ID: 32172363
[TBL] [Abstract][Full Text] [Related]
6. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors: new drugs and indications.
Mears JM; Kaplan B
Am Fam Physician; 1996 Jan; 53(1):285-92. PubMed ID: 8546054
[TBL] [Abstract][Full Text] [Related]
8. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
Masubuchi N; Hakusui H; Okazaki O
Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597
[TBL] [Abstract][Full Text] [Related]
9. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
11. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
Levine A; Shevah O; Shabat-Sehayek V; Aeed H; Boaz M; Moss SF; Niv Y; Avni Y; Shirin H
Aliment Pharmacol Ther; 2004 Jul; 20(1):117-22. PubMed ID: 15225178
[TBL] [Abstract][Full Text] [Related]
12. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
[TBL] [Abstract][Full Text] [Related]
13. Effect of proton pump inhibitors on hepatic regeneration.
Kucuk HF; Akyol H; Kaptanoglu L; Kurt N; Barisik NO; Bingul S; Torlak OA; Colak E
Eur Surg Res; 2006; 38(3):322-8. PubMed ID: 16785731
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]